Annual report pursuant to Section 13 and 15(d)

Income Taxes - Narrative (Details)

v3.22.4
Income Taxes - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Taxes    
Net operating loss carryforwards $ 22,168,000  
Net change in valuation allowance 3,100,898 $ 3,745,299
Deferred Tax Assets, Capitalized Research and Development Expenses 1,873,211  
Capitalized research and development expenses $ 8,099,702